Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...tis, endocarditis, osteomyelitis, severe sepsis, and toxinoses such as toxic shock syndrome. A multifactorial range of independent risk factors for MRSA has been reported in literature and include immunosuppression,hemodialysis, peripheral malperfusion, advanced age, extended in-hospital stays, residency in long-term care facilities (LTCFs), inadequacy of antimicrobial therapy,indwelling devices, insulin-requiring diabetes, and decubitusulcers, among others.
Hindawi Canadian Journal of Infectious Diseases and Medical Microbiology Volume 2019, Article ID 8321834, 9 pageshttps://doi.org/10.1155/2019/8321834
more
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...y ‘Supporting Surveillance Capacity for Antimicrobial Resistance: Regional Networks and Educational Resources’. This study compares antimicrobial surveillance systems in three low and middle income countries in order to describe the components of these systems and to understand which surveillance models are best suited to particular contexts. Ghana, Nigeria and Nepal were selected as study countries because they cover different continents and include one ‘fragile’ context (Nigeria). Brief information from Malawi is also included.
more
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2011 and 2012 data currently available from their re...levant five EU monitoring networks. Combined data on antimicrobial consumption and corresponding resistance in animals and humans for EU MSs and reporting countries were analysed using logistic regression models for selected combinations of bacteria and antimicrobials. A summary indicator of the proportion of resistant bacteria in the main food-producing animal species was calculated for the analysis, as consumption data in food-producing animals were not available at the species level
more
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...antimicrobial drugs. The rapid rate with which antimicrobial agents are becoming ineffective due to resistance acquired as a result of unchecked overuse and misuse threatens to undo the benefit of controlling infections. The evidence for resistant microorganisms, many times to more than a single antimicrobial agent, has been observed globally. In Tanzania, there is evidence in the form of few scattered studies conducted in different parts of the country in a multitude of settings including health care facilities, the community, domesticated animals and wild animals
more
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...ther-ing original data and information from Member States, in supporting the process of aggregation of these data; and in reviewing the regional analysis of the findings that reflect the country situation at the point when the survey was conducted. The support and commitment of the members of the WHO Task Force on Antimicrobial Resistance, comprising WHO staff from Headquarters and Regional Offices has, is also acknowledged.
more
Des mains propressont des mains sûres. Mes mains sont-elles propres ?
Les infections associées aux soins (IAS) constituent une menace sérieuse dont l’impact économique pour les patients et les systèmes de santé dans le monde entier est significatif. Pourtant, la pratique de l’hygiène des mains – le simple fait d’assurer l’antisepsie des mains au moment... opportun et de manière appropriée – permettrait de sauver des vies.
more
A l’attention des professionnels soignants, des formateurs et des observateurs des pratiques d’hygiène des mains
Epidemiologisches Bulletin 14 | 2020 Online vorab: 27. März 2020
Epid Bull 2020;14:3 – 9 | DOI 10.25646/6601
Rapporto ISS COVID-19, n. 6/2020
Gruppo di Lavoro ISS Cause di morte COVID-19
Versione del 27 marzo 2020
Indicazioni ad interim - Per un utilizzo regionale delle protezioni per infezione da SARS-CoV-2 nelle attività sanitarie e sociosanitarie (Assistenza a soggetti affetti da CoVID-19) nell’attuale scenario emergenziale SARS-CoV-2
Rapporto ISS COVID-19, n. 4/2020
Gruppo di Lavoro ISS Prevenzione e Controllo delle Infezioni
aggiornato al 16 marzo 2020
Rapporto ISS COVID-19, n. 5/2020
Gruppo di Lavoro ISS Ambiente e Qualità dell’Aria Indoor
versione del 23 marzo 2020
Antibiotic stewardship refers to coordinated efforts and activities that seek to measure and improve use of antibiotics. Implementation of ASPs has demonstrated positive public health and clinical impacts including reducing costs, lengths of hospital stays, and the burden of antibiotic resistance wh...ile maintaining or improving patient outcomes. The U.S. Centers for Disease Control and Prevention (CDC) released the Core Elements of Hospital Antibiotic Stewardship Programs in 2014, which outlines essential components for ASPs in hospitals and provides practical guidance for implementing a robust ASPin an acute care facility. Variations to the Core Elements have been developed to deal with the particular challenges in small, rural or critical access hospitals in the United States and in outpatient facilities and nursing homes.
more
The primary focus of the plan continues to be prevention, preparedness and treatment of the the Novel Coronavirus (COVID-19) outbreak. Central to the plan are the following overall objectives:
To prevent further transmission of COVID-19 in the oPt;
To provide adequate care for patients aff...ected by COVID-19 and to support their families and close contacts; and
To mitigate the worst effects of the pandemic.
more
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ... diarrhoeagenic Escherichia coli and invasive non-‐typhi salmonella, penicillin-‐resistant Streptococcus pneu-‐moniae, vancomycin-‐resistant enterococci, methicillin-‐resistant Staphylococcus aureus and multidrug-‐re-‐sistant Mycobacterium tuberculosis. Resistance to medicines commonly used to treat malaria is of particu-‐lar concern, as is the emerging resistance to anti-‐HIV drugs. Often, more expensive medicines are required to treat these infections, and this becomes a major challenge in resource-‐poor settings.
more
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...sistance Surveillance System (GLASS), the first global collaborative effort to foster AMR surveillance in bacteria causing acute infections. As of December 2018, 71 countries are enrolled in GLASS. The aim of this report is to document participation efforts and outcomes across these countries, and highlight differences and constraints identified to date. This report follows on from the first GLASS Report – Early implementation 2016-17, published in January 2018, and drawing on data from GLASS first data call in 2017.
more
Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr...eased predisposition to infec-tion by fungi and Clostridium difficile. Antibiotic resistance has become a major public health concern, with fears expressed that we will soon run out of antibiotics.
Haematologica December 2013 98: 1821-1825; doi:10.3324/haematol.2013.091769
more
COVID-19 gibi bulaşıcı hastalıklar, çocukların büyüyüp geliştiği ortamlara zarar verebilir. Ailelerde, arkadaşlıklarda, günlük rutinlerde ve toplumda yaşanan aksamalar çocukların iyi olma hali, gelişimi ve korunması bakımından olumsuz sonuçlar doğurabilir. Ayrıca, COVID-19...un yayılmasını önlemek ve kontrol altına almak için uygulanan tedbirler, çocukları korumayla ilgili risklere maruz bırakabilir. Evlerde, kurum ve kuruluşlarda ve bölgelerde uygulanan karantina ve izolasyon tedbirlerinin çocuklar ve aileleri üzerinde olumsuz etkileri olabilir
Bu bilgilendirmenin amacı, COVID-19 pandemisi sırasında çocuk koruma risklerine daha iyi müdahale edebilmeleri için çocuk koruma uzmanlarına destek sunmaktır. 1. Bölümde COVID-19’un çocuklar açısından ortaya çıkmasına neden olabileceği olası çocuk koruma riskleri sunulmuştur. 2. Bölümde ise İnsani Yardım Hareketinde Çocuk Korumaya Yönelik Asgari Standartlar (2019) ile Kılavuz Notu: Bulaşıcı Hastalık Salgınları Sırasında Çocukların Korunması belgelerine uygun program seçenekleri sunulmuştur.
more